Relevance of nanotechnology in modulating oxidative stress: An overview

Methods in Molecular Biology

Volumn 1028, Issue , 2013, Pages 289-292

  Bharali, Dhruba J ^a   Mousa, Shaker A ^a  

^a ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

Author keywords

Anticancer drugs; Antioxidant; Half life; Nanotechnology; Natural products; Oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; BETA CAROTENE; BIOLOGICAL PRODUCT; CERIUM OXIDE; CURCUMIN; EXCIPIENT; NANOPARTICLE; PACLITAXEL; SILVER NANOPARTICLE;

ARTICLE; HUMAN; LIFE EXPECTANCY; MEDICAL RESEARCH; MOLECULAR WEIGHT; NANOTECHNOLOGY; NEOPLASM; OXIDATIVE STRESS; PREVENTIVE MEDICINE; PRIORITY JOURNAL; QUALITY OF LIFE;

EID: 84883247391     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-475-3_19     Document Type: Article

References (17)

1. Wachtel-Galor S, Benzie IFF (2011) Herbal medicine: An introduction to its history, usage, regulation, current trends, and research needs. CRC Press, Boca Raton, FL
2. Pietta PG (2000) Flavonoids as antioxidants. J Nat Prod 63(7):1035-1042
3. Bawarski WE et al (2008) Emerging nanopharmaceuticals. Nanomedicine 4(4):273-282
4. Siddiqui IA et al (2009) Introducing nanochemoprevention as a novel approach for cancer control: Proof of principle with green tea polyphenol epigallocatechin-3-gallate. Cancer Res 69(5):1712-1716
5. Ranjan AP et al (2012) Scale up, optimization and stability analysis of Curcumin C3 complexloaded nanoparticles for cancer therapy. J Nanobiotechnol 10(1):38
6. Lim KJ et al (2011) A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors. Cancer Biol Ther 11(5): 464-473
7. Yusuf M et al (2012) Plausible antioxidant biomechanics and anticonvulsant pharmacological activity of brain-Targeted beta-carotene nanoparticles. Int J Nanomedicine 7:4311-4322
8. Lian H et al (2011) Supramolecular micellar nanoaggregates based on a novel chitosan/ vitamin E succinate copolymer for paclitaxel selective delivery. Int J Nanomedicine 6: 3323-3334
9. Celardo I, Traversa E, Ghibelli L (2011) Cerium oxide nanoparticles: A promise for applications in therapy. J Exp Ther Oncol 9(1): 47-51
10. Carlotti ME et al (2009) Specifi c effects of single antioxidants in the lipid peroxidation caused by nano-Titania used in sunscreen lotions. J Photochem Photobiol B 96(2):130-135
11. Dimitrijevic NM, Rozhkova E, Rajh T (2009) Dynamics of localized charges in dopaminemodifi ed TiO(2) and their effect on the formation of reactive oxygen species. J Am Chem Soc 131(8):2893-2899
12. Dowding JM et al (2012) Cerium oxide nanoparticles scavenge nitric oxide radical (NO). Chem Commun (Camb) 48(40):4896-4898
13. http://www.nano.gov/about-nni/what/ funding . Accessed 16 Apr, 2013
14. Fako VE, Furgeson DY (2009) Zebrafi sh as a correlative and predictive model for assessing biomaterial nanotoxicity. Adv Drug Deliv Rev 61(6):478-486
15. The Freedonia Group, Inc. (2007) US demand for nanotechnology medical products to approach $53 billion in 2011-Report. The Freedonia Group, Inc., Cleveland, OH. http :// nanotechwire.com/news.asp?nid=4446 . Accessed 16 Apr, 2013
16. 2011, 2016 & 2021. The Freedonia Group, Inc., Cleveland, OH, p 350
17. Lux Research (2006) The Nanotech Report™: Investment overview and market research for nanotechnology. Lux Research, New York, NY